Klinikum rechts der Isar der TU München; Augenklinik
Munchen, Germany
Ophthalmology clinic in Munich, Bavaria
Ismaninger Str. 22, 81675 München
About Klinikum rechts der Isar der TU München; Augenklinik
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Lux Biosciences, Inc.
2
Clinical Trials at Klinikum rechts der Isar der TU München; Augenklinik
During the past decade, Klinikum rechts der Isar der TU München; Augenklinik conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk
2007-04-01
2010-11-01
Terminated
368
Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty
2007-04-01
2010-01-01
Terminated
122
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-10-06
2018-01-23
Terminated
975
A Study of Disease Progression in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2015-06-24
2018-01-31
Terminated
296
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
2016-07-21
2018-01-31
Terminated
994
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
2018-10-09
2021-08-27
Completed
951
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
2020-08-05
2023-08-18
Active, not recruiting
1,479
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Klinikum rechts der Isar der TU München; Augenklinik
According to Clinical.Site data, the most researched conditions in "Klinikum rechts der Isar der TU München; Augenklinik" are
"Geographic Atrophy" (3 trials), "Diabetic Macular Edema" (2 trials), "Cornea Transplant" (1 trials), "Corneal Diseases" (1 trials) and "Corneal Graft Rejection" (1 trials). Many other conditions were trialed in "Klinikum rechts der Isar der TU München; Augenklinik" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum rechts der Isar der TU München; Augenklinik
Most popular intervention types in "Klinikum rechts der Isar der TU München; Augenklinik" are "Drug" (6 trials), "Other" (5 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (2 trials), "LX201" (2 trials), "Lampalizumab" (2 trials), "Placebo" (2 trials) and "Sham Procedure" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum rechts der Isar der TU München; Augenklinik
The vast majority of trials in "Klinikum rechts der Isar der TU München; Augenklinik" are
7 trials for "All" genders.
Clinical Trials Status at Klinikum rechts der Isar der TU München; Augenklinik
Currently, there are NaN active trials in "Klinikum rechts der Isar der TU München; Augenklinik".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Klinikum rechts der Isar der TU München; Augenklinik,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum rechts der Isar der TU München; Augenklinik, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".